Director/PDMR Shareholding
Summary by AI BETAClose X
Dr. Martens plc (the 'Company')
Director/PDMR Shareholding
Notification of Transactions by Directors/Persons Discharging Managerial Responsibility
The Company announces that it was notified on 12 February 2026 of the following transactions in the Company's Ordinary 1p shares undertaken by directors / persons discharging managerial responsibility ('PDMRs') under the Company's Share Incentive Plan ('SIP').
The SIP is an HMRC approved, all-employee scheme under which participating employees are able to purchase shares in the Company from monthly salary ('Partnership Shares') and receive allocations of free 'Matching Shares', awarded at a rate of one Matching Share for every one Partnership Share purchased by a participating employee, from the Company.
On 11 February 2026, the following directors / PDMRs acquired Partnership Shares as a result of their participation in the SIP at a price of 68.75 pence per share and were granted an allocation of Matching Shares (for no consideration) in the quantity set out in the table below:
|
Director / PDMR |
Number of Partnership Shares purchased |
Number of |
|
Ije Nwokorie |
219 |
219 |
|
Giles Wilson |
219 |
219 |
The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||||||||||||||||
|
a) |
Name |
Ije Nwokorie |
||||||||||||||||||||
|
2 |
Reason for the notification |
|||||||||||||||||||||
|
a) |
Position/status |
PDMR (Chief Executive Officer) |
||||||||||||||||||||
|
b) |
Initial notification/Amendment |
Initial notification |
||||||||||||||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||||||||||||||
|
a) |
Name |
Dr. Martens plc |
||||||||||||||||||||
|
b) |
LEI |
213800QPT8YM6NQZPH28 |
||||||||||||||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||||||||||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of GBP 0.01
|
||||||||||||||||||||
|
b) |
Nature of the transaction |
1. Purchase of Partnership Shares under the SIP 2. Award of Matching Shares under the SIP |
||||||||||||||||||||
|
c) |
Price(s) and volume(s) |
|
||||||||||||||||||||
|
d) |
Aggregated information
|
|
||||||||||||||||||||
|
e) |
Date of the transaction |
11 February 2026 |
||||||||||||||||||||
|
f) |
Place of the transaction |
1. London Stock Exchange (XLON) 2. Outside of a trading venue |
||||||||||||||||||||
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||||||||||||||||
|
a) |
Name |
Giles Wilson |
||||||||||||||||||||
|
2 |
Reason for the notification |
|||||||||||||||||||||
|
a) |
Position/status |
PDMR (Chief Financial Officer) |
||||||||||||||||||||
|
b) |
Initial notification/Amendment |
Initial notification |
||||||||||||||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||||||||||||||
|
a) |
Name |
Dr. Martens plc |
||||||||||||||||||||
|
b) |
LEI |
213800QPT8YM6NQZPH28 |
||||||||||||||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||||||||||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of GBP 0.01
|
||||||||||||||||||||
|
b) |
Nature of the transaction |
1. Purchase of Partnership Shares under the SIP 2. Award of Matching Shares under the SIP |
||||||||||||||||||||
|
c) |
Price(s) and volume(s) |
|
||||||||||||||||||||
|
d) |
Aggregated information
|
|
||||||||||||||||||||
|
e) |
Date of the transaction |
11 February 2026 |
||||||||||||||||||||
|
f) |
Place of the transaction |
1. London Stock Exchange (XLON) 2. Outside of a trading venue |
||||||||||||||||||||
For further information please contact:
Rebecca Flaherty
Assistant Company Secretary
+44(0)7585 3982165
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 4 hours ago Oxford Nanopore Technologies
- 4 hours ago AVI Global Trust
- 5 hours ago LSL Property Services
- 5 hours ago Bluebird Merchant Ventures (DI)
- 5 hours ago Power Probe PLC